Cisplatin

Title	Average Rating
Metronomic schedule of temozolomide with conventional dose of cisplatin in metastatic melanoma. Sub-category: Melanoma Categor	90.00%
Hyperthermia adds to chemotherapy.	90.00%
Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled	80.00%
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients ....	80.00%
Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual sta	80.00%
Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer.	70.00%
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer	70.00%
Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy.	70.00%
Clinical management of adrenocortical carcinoma	60.00%
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer	50.00%
Preclinical antitumor and antiangiogenic activity of a metronomic schedule of cisplatin against human transitional cell carcinom	50.00%
Final analysis of a multicenter, randomized phase II trial comparing three different chemoradiotherapy regimens in the treatment	30.00%
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.

Languages